Location History:
- Ibaraki, JP (1998 - 2014)
- Moriguchi, JP (2014)
- Tukuba, JP (2014 - 2016)
- Tsukuba, JP (1996 - 2020)
Company Filing History:
Years Active: 1996-2020
Title: Akifumi Iwama: Innovator in Nucleic Acid Detection and Sterilization Technology
Introduction
Akifumi Iwama is a prominent inventor based in Tsukuba, Japan, known for his significant contributions to the fields of nucleic acid detection and sterilization technology. With a total of 13 patents to his name, Iwama has developed innovative solutions that enhance the accuracy and efficiency of various scientific processes.
Latest Patents
Iwama's latest patents include a method for detecting nucleic acid amplification products in real time. This apparatus effectively reduces apparatus error factors without the need for a second fluorescence signal used for correction. The system allows for real-time detection of fluorescence strength from nucleic acid amplification products across multiple wells, ensuring precise measurements. Another notable invention is an isolator that features a work chamber, a sterilizing substance supply unit, and a gas flow channel pressure adjustment unit. This isolator is designed to perform gas flow channel leak tests while simultaneously controlling the supply of sterilizing substances, showcasing Iwama's commitment to advancing laboratory safety and efficiency.
Career Highlights
Throughout his career, Akifumi Iwama has worked with notable companies such as Panasonic Healthcare Co., Ltd. and Sanyo Electric Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking technologies in healthcare and electronics.
Collaborations
Iwama has collaborated with esteemed colleagues, including Yasuhiko Yokoi and Jiro Ohnishi, further enhancing his innovative projects and expanding the impact of his work in the scientific community.
Conclusion
Akifumi Iwama's contributions to nucleic acid detection and sterilization technology exemplify his dedication to innovation and excellence. His patents reflect a deep understanding of scientific challenges and a commitment to developing effective solutions.